Solomon, Alina
Stephen, Ruth
Altomare, Daniele http://orcid.org/0000-0003-1905-8993
Carrera, Emmanuel
Frisoni, Giovanni B.
Kulmala, Jenni
Molinuevo, José Luis
Nilsson, Peter
Ngandu, Tiia
Ribaldi, Federica
Vellas, Bruno
Scheltens, Philip
Kivipelto, Miia
Abramowicz, Marc
Altomare, Daniele
Barkhof, Frederik
Berthier, Marcelo
Bieler, Melanie
Blennow, Kaj
Brayne, Carol
Brioschi, Andrea
Carrera, Emmanuel
Chételat, Gael
Csajka, Chantal
Demonet, Jean-François
Dodich, Alessandra
Dubois, Bruno
Frisoni, Giovanni B.
Garibotto, Valentina
Georges, Jean
Hurst, Samia
Jessen, Frank
Kivipelto, Miia
Llewellyn, David
Mcwhirter, Laura
Milne, Richard
Minguillón, Carolina
Miniussi, Carlo
Molinuevo, José Luis
Nilsson, Peter M.
Ranson, Janice
Ribaldi, Federica
Ritchie, Craig
Scheltens, Philip
Solomon, Alina
van Duijn, Cornelia
van der Flier, Wiesje
Vellas, Bruno
Visser, Leonie
,
Funding for this research was provided by:
Swiss National Science Foundation (IZSEZ0_193593)
Article History
Received: 28 January 2021
Accepted: 6 July 2021
First Online: 11 October 2021
Change Date: 23 October 2021
Change Type: Update
Change Details: The paper was amended to add a DOI in references part of the Brain Health Services series.
Declarations
:
: Not applicable.
: Not applicable.
: GBF reports grants from Alzheimer Forum Suisse, Académie Suisse des Sciences Médicales, Avid Radiopharmaceuticals, Biogen, GE International, Guerbert, Association Suisse pour la Recherche sur l’Alzheimer, IXICO, Merz Pharma, Nestlé, Novartis, Piramal, Roche, Siemens, Teva Pharmaceutical Industries, Vifor Pharma, and Alzheimer’s Association; he has received personal fees from AstraZeneca, Avid Radiopharmaceuticals, Elan Pharmaceuticals, GE International, Lundbeck, Pfizer, and TauRx Therapeutics.JLM is currently a full-time employee of Lundbeck, has previously served as a consultant or at advisory boards for the following for-profit companies, or has given lectures in symposia sponsored by the following for-profit companies: Roche Diagnostics, Genentech, Novartis, Lundbeck, Oryzon, Biogen, Lilly, Janssen, Green Valley, MSD, Eisai, Alector, BioCross, GE Healthcare, and ProMIS Neurosciences.PS has received consultancy fees (paid to the institution) from AC Immune, Alkermes, Alnylam, Anavex, Biogen, Brainstorm Cell, Cortexyme, Denali, EIP, ImmunoBrain Checkpoint, GemVax, Genentech, Green Valley, Novartis, Novo Noridisk, PeopleBio, Renew LLC, and Roche. He is a PI of studies with AC Immune, CogRx, FUJI-film/Toyama, IONIS, UCB, and Vivoryon. He serves on the board of the Brain Research Center.The other authors declare that they have no competing interests.